Nautilus Biotechnology (NAUT) Interest & Investment Income (2021 - 2026)

Nautilus Biotechnology has disclosed Interest & Investment Income across 6 years of filings, most recently posting $1.3 million for Q2 2026.

• In Q2 2026, Interest & Investment Income fell 37.16% year-over-year to $1.3 million; the TTM figure through Jun 2026 stood at $6.3 million (down 33.03% YoY), while the FY2025 annual figure was $7.9 million, down 27.01% from the prior year.
• Interest & Investment Income came in at $1.3 million for Q2 2026 at Nautilus Biotechnology, down from $1.4 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $3.2 million in Q2 2023 to a low of $264000.0 in Q1 2022.
• Average Interest & Investment Income over 5 years is $2.2 million, with a median of $2.3 million recorded in 2024.
• Year-over-year, Interest & Investment Income surged 1693.17% in 2022 and sank 37.16% in 2026.
• Over 5 years, Interest & Investment Income stood at $2.9 million in 2022, then gained by 5.06% to $3.0 million in 2023, then dropped by 19.85% to $2.4 million in 2024, then slumped by 31.96% to $1.7 million in 2025, then retreated by 20.98% to $1.3 million in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $1.3 million in Q2 2026, $1.4 million in Q1 2026, and $1.7 million in Q4 2025.